Article

Supernormal Greens - Ljusgarda has pivoted from lettuce to large-scale production of medicinal plants, transitioning over ten species from research to commercial viability. Co-founder Erik Lundgren details a process combining ethnobotany and modern science to optimize for compound density rather than fresh biomass.

Current species under production include Ocimum sanctum, Plantago lanceolata, and Borago officinalis. The company utilizes precision elicitation to activate plants' natural defenses, enhancing high-value compounds for various applications. This shift also changes performance metrics from weight to functional potency, focusing on the concentration and reproducibility of bioactive compounds.